Abstract
Background HIV-1 is associated with accelerated aging. The senescence-associated secretory phenotype (SASP) includes biological and cytokine profiles that induce cellular senescence and inflammaging. In this study, we leveraged the Multicenter AIDS Cohort Study (MACS) to evaluate the role of SASP in aging, HIV-1 reservoir, and inflammation in people with HIV-1 (PWH) on long-term suppressive antiretroviral therapy (ART).
Methods In this retrospective study we included plasma and serum samples from 27 virally- suppressed PWH and 10 people without HIV-1 (PWoH) collected in 2019 and 2023. SASP markers were quantified in the 2019 and 2023 samples. Plasma residual viremia, intact and defective proviral DNA were quantified in the 2019 samples. Correlations between SASP markers and HIV-1 reservoir were performed using the Spearman test, and the sparse partial least squares discrimination analysis was used to identify variables that distinguish HIV-1 serostatus.
Results All study participants were male with a median age of 59 years. SASP markers did not show significant changes longitudinally in either group. We identified a set of markers that had moderate performance in distinguishing PWH and PWoH, including CMV serum antibody titer, matrix metalloproteinase 9 (MMP-9), Growth/differentiation factor-15, Stanniocalcin-1 and SerpinE1. Among all the SASP markers, MMP-9 was significantly associated with intact HIV-1 proviral levels (rho=0.60, P=0.002).
Conclusion In this cohort study, we revealed the relationship between SASP markers and HIV-1 persistence. Future interventions targeting the senescence pathways may impact HIV-1 persistence.
Competing Interest Statement
This study was funded in part by the National Heart, Lung, and Blood Institute (U01-HL146208), the MWCCS Data Analysis and Coordination Center (U01‐HL146193), and the Rustbelt Center for AIDS Research (P30 AI036219), together with internal funding from the Department of Medicine, University of Pittsburgh School of Medicine. The contents of this publication are solely the responsibility of the authors and do not represent the official views of the National Institutes of Health (NIH).
Funding Statement
This study was funded in part by the National Heart, Lung, and Blood Institute (U01-HL146208), the MWCCS Data Analysis and Coordination Center (U01‐HL146193), and the Rustbelt Center for AIDS Research (P30 AI036219), together with internal funding from the Department of Medicine, University of Pittsburgh School of Medicine. The contents of this publication are solely the responsibility of the authors and do not represent the official views of the National Institutes of Health (NIH).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study is approved by University of Pittsburgh IRB.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Funding: This study was funded in part by the National Heart, Lung, and Blood Institute (U01-HL146208), the MWCCS Data Analysis and Coordination Center (U01‐HL146193), and the Rustbelt Center for AIDS Research (P30 AI036219), together with internal funding from the Department of Medicine, University of Pittsburgh School of Medicine. The contents of this publication are solely the responsibility of the authors and do not represent the official views of the National Institutes of Health (NIH).
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.